New meningitis shot for babies passes major safety test

NCT ID NCT03621670

Completed ⭐️ VACCINE ⭐️ Sponsor: GlaxoSmithKline Source: ClinicalTrials.gov ↗

Summary

This study tested the safety and immune response of a new vaccine (Bexsero) designed to protect infants from a serious type of bacterial meningitis (Meningococcal Group B). Over 1,100 healthy babies, aged 6 to 12 weeks, received the new vaccine along with their standard infant immunizations, including a pneumonia vaccine. Researchers closely monitored the babies for side effects and checked if their bodies produced a strong protective immune response.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

GSK Investigational Site

Birmingham, Alabama, 35205, United States
GSK Investigational Site

Fayetteville, Arkansas, 72703, United States
GSK Investigational Site

Jonesboro, Arkansas, 72401, United States
GSK Investigational Site

Anaheim, California, 92804, United States
GSK Investigational Site

Oakland, California, 94611, United States
GSK Investigational Site

Roseville, California, 95661, United States
GSK Investigational Site

Walnut Creek, California, 94596, United States
GSK Investigational Site

West Covina, California, 91790, United States
GSK Investigational Site

Lake Mary, Florida, 32746, United States
GSK Investigational Site

Miami, Florida, 33142, United States
GSK Investigational Site

Tampa, Florida, 33613, United States
GSK Investigational Site

Nampa, Idaho, 83686, United States
GSK Investigational Site

Nampa, Idaho, 83702, United States
GSK Investigational Site

Newton, Kansas, 67114, United States
GSK Investigational Site

Topeka, Kansas, 66604, United States
GSK Investigational Site

Bardstown, Kentucky, 40004, United States
GSK Investigational Site

Louisville, Kentucky, 40202, United States
GSK Investigational Site

Louisville, Kentucky, 40207, United States
GSK Investigational Site

Louisville, Kentucky, 40291, United States
GSK Investigational Site

Baltimore, Maryland, 21021, United States
GSK Investigational Site

Fall River, Massachusetts, 02721, United States
GSK Investigational Site

Bingham Farms, Michigan, 48025, United States
GSK Investigational Site

Kansas City, Missouri, 64108, United States
GSK Investigational Site

Lincoln, Nebraska, 68516, United States
GSK Investigational Site

Omaha, Nebraska, 68128, United States
GSK Investigational Site

Liverpool, New York, 13090, United States
GSK Investigational Site

Syracuse, New York, 13210, United States
GSK Investigational Site

Boone, North Carolina, 28607, United States
GSK Investigational Site

Raleigh, North Carolina, 27609, United States
GSK Investigational Site

Cincinnati, Ohio, 45245, United States
GSK Investigational Site

Dayton, Ohio, 45406, United States
GSK Investigational Site

Dayton, Ohio, 45414, United States
GSK Investigational Site

Fairfield, Ohio, 45014, United States
GSK Investigational Site

South Euclid, Ohio, 44121, United States
GSK Investigational Site

Hermitage, Pennsylvania, 16148, United States
GSK Investigational Site

Pittsburgh, Pennsylvania, 15224, United States
GSK Investigational Site

Charleston, South Carolina, 29406, United States
GSK Investigational Site

Sioux Falls, South Dakota, 57105, United States
GSK Investigational Site

Clarksville, Tennessee, 37040, United States
GSK Investigational Site

Kingsport, Tennessee, 37660, United States
GSK Investigational Site

Beaumont, Texas, 77706, United States
GSK Investigational Site

Bryan, Texas, 77802, United States
GSK Investigational Site

Edinburg, Texas, 78504, United States
GSK Investigational Site

Houston, Texas, 77065, United States
GSK Investigational Site

Houston, Texas, 77090, United States
GSK Investigational Site

San Antonio, Texas, 78229, United States
GSK Investigational Site

San Antonio, Texas, 78244, United States
GSK Investigational Site

Layton, Utah, 84041, United States
GSK Investigational Site

Orem, Utah, 84057, United States
GSK Investigational Site

Provo, Utah, 84604, United States
GSK Investigational Site

Roy, Utah, 84067, United States
GSK Investigational Site

Salt Lake City, Utah, 84121, United States
GSK Investigational Site

Syracuse, Utah, 84075, United States
GSK Investigational Site

Richmond, Virginia, 23298, United States
GSK Investigational Site

Spokane, Washington, 99202, United States
GSK Investigational Site

Marshfield, Wisconsin, 54449, United States
GSK Investigational Site

San Juan, 00907, Puerto Rico

Conditions

Explore the condition pages connected to this study.

INFECTIONS, MENINGOCOCCAL